These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 10843460)

  • 21. Impact of hospital guideline for weight-based antimicrobial dosing in morbidly obese adults and comprehensive literature review.
    Polso AK; Lassiter JL; Nagel JL
    J Clin Pharm Ther; 2014 Dec; 39(6):584-608. PubMed ID: 25203631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimisation of antibiotic therapy in cystic fibrosis patients. Pharmacokinetic considerations.
    Lindsay CA; Bosso JA
    Clin Pharmacokinet; 1993 Jun; 24(6):496-506. PubMed ID: 8513651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical pharmacokinetics of antimicrobial drugs in cystic fibrosis.
    Touw DJ
    Pharm World Sci; 1998 Aug; 20(4):149-60. PubMed ID: 9762727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic drug monitoring of vancomycin in a morbidly obese patient.
    Penzak SR; Gubbins PO; Rodvold KA; Hickerson SL
    Ther Drug Monit; 1998 Jun; 20(3):261-5. PubMed ID: 9631922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic optimisation of antibacterial treatment in patients with cystic fibrosis. Current practice and suggestions for future directions.
    Touw DJ; Vinks AA; Mouton JW; Horrevorts AM
    Clin Pharmacokinet; 1998 Dec; 35(6):437-59. PubMed ID: 9884816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Updated antimicrobial dosing recommendations for obese patients.
    Castro-Balado A; Varela-Rey I; Mejuto B; Mondelo-García C; Zarra-Ferro I; Rodríguez-Jato T; Fernández-Ferreiro A
    Antimicrob Agents Chemother; 2024 May; 68(5):e0171923. PubMed ID: 38526051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pediatric Obesity: Pharmacokinetics and Implications for Drug Dosing.
    Kendrick JG; Carr RR; Ensom MH
    Clin Ther; 2015 Sep; 37(9):1897-923. PubMed ID: 26361823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of drugs in obesity.
    Abernethy DR; Greenblatt DJ
    Clin Pharmacokinet; 1982; 7(2):108-24. PubMed ID: 7039924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical pharmacokinetics of antibacterial drugs in the elderly. Implications for selection and dosage.
    Meyers BR; Wilkinson P
    Clin Pharmacokinet; 1989 Dec; 17(6):385-95. PubMed ID: 2689039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vancomycin dosing in morbidly obese patients.
    Bauer LA; Black DJ; Lill JS
    Eur J Clin Pharmacol; 1998 Oct; 54(8):621-5. PubMed ID: 9860149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of aminoglycoside and vancomycin pharmacokinetic parameters.
    Wragge TM; Cooper BE
    Ann Pharmacother; 1993 Nov; 27(11):1346-8. PubMed ID: 8286806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pediatric Obesity: Pharmacokinetic Alterations and Effects on Antimicrobial Dosing.
    Natale S; Bradley J; Nguyen WH; Tran T; Ny P; La K; Vivian E; Le J
    Pharmacotherapy; 2017 Mar; 37(3):361-378. PubMed ID: 28079262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial therapy in neonates, infants and children.
    Brown RD; Campoli-Richards DM
    Clin Pharmacokinet; 1989; 17 Suppl 1():105-15. PubMed ID: 2692934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vancomycin pharmacokinetics in neonates and infants: a retrospective evaluation.
    Asbury WH; Darsey EH; Rose WB; Murphy JE; Buffington DE; Capers CC
    Ann Pharmacother; 1993 Apr; 27(4):490-6. PubMed ID: 8477127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and administration regimens of vancomycin in neonates, infants and children.
    Rodvold KA; Everett JA; Pryka RD; Kraus DM
    Clin Pharmacokinet; 1997 Jul; 33(1):32-51. PubMed ID: 9250422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dosing of antibacterial agents in obese adults: does one size fit all?
    Payne KD; Hall RG
    Expert Rev Anti Infect Ther; 2014 Jul; 12(7):829-54. PubMed ID: 24809811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vancomycin trough concentrations in overweight or obese pediatric patients.
    Heble DE; McPherson C; Nelson MP; Hunstad DA
    Pharmacotherapy; 2013 Dec; 33(12):1273-7. PubMed ID: 23798327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aminoglycoside dosing weight correction factors for patients of various body sizes.
    Traynor AM; Nafziger AN; Bertino JS
    Antimicrob Agents Chemother; 1995 Feb; 39(2):545-8. PubMed ID: 7726530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antibiotics and overweight].
    Madsen H; Brøsen K; Frimodt-Møller N; Gahrn-Hansen B
    Ugeskr Laeger; 2005 May; 167(21):2266-70. PubMed ID: 15962851
    [No Abstract]   [Full Text] [Related]  

  • 40. Population pharmacokinetics of vancomycin in obesity: Finding the optimal dose for (morbidly) obese individuals.
    Smit C; Wasmann RE; Goulooze SC; Wiezer MJ; van Dongen EPA; Mouton JW; Brüggemann RJM; Knibbe CAJ
    Br J Clin Pharmacol; 2020 Feb; 86(2):303-317. PubMed ID: 31661553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.